Nuvalent Inc - Class A — Dividend History & Yield (NASDAQ:NUVL) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

新闻

Nuvalent公布第四季度亏损,等待FDA对肺癌药物的决定

Nuvalent reports Q4 loss, awaits FDA decision on lung cancer drug

Drugmakers turn to AI to speed trials, regulatory submissions

Nuvalent Inc股票触及52周高点112.89美元

Nuvalent Inc stock hits 52-week high at 112.89 USD

FDA接受Nuvalent针对ROS1阳性非小细胞肺癌治疗的新药申请

FDA accepts Nuvalent’s NDA for ROS1-positive NSCLC treatment

Nuvalent (NUVL) chief legal officer Miller sells $676k in stock

Nuvalent CSO Pelish sells shares worth $501,752

Nuvalent (NUVL) chief development officer sells $721k in stock

What's Going On With Royalty Pharma Stock Wednesday? - Royalty Pharma (NASDAQ:RPRX)

3 Biotech Stocks With Major 2026 Catalysts